<DOC>
	<DOCNO>NCT00580905</DOCNO>
	<brief_summary>The purpose study extend previous observation animal model regard effect adenosine release cytokine human subject . We intend accomplish two study protocol . In first infuse intravenously adenosine measure plasma level inflammatory cytokine . In second one , use microdialysis technique infuse intradermally small amount adenosine measure skin blood flow take biopsy measure level mRNA cytokine .</brief_summary>
	<brief_title>Role Adenosine Release VEGF Cytokines</brief_title>
	<detailed_description>In Protocol 1 infuse adenosine dose 80 mcg/kg/min 30 minute measure plasma level adenosine different time point , range 30 minute 6 hour . Because activation A2B receptor also mediate release inflammatory cytokine , include IL-6 , sample take measure inflammatory/angiogenic cytokine . In second protocol , administer adenosine intradermically via microdialysis probe 30 minute measure local effect skin blood flow use laser Doppler technique . One hour end infusion obtain skin biopsy perfuse area measurement mRNA VEGF , IL-8 , IL-6 cytokine . In addition , foresee possibility test look genetic association angiogenesis adenosine . These proof-of-concept pilot study . We study 12 subject protocol interim analysis perform 6 subject study . This help u determine trend observe , perform power calculation , determine extensive study warrant .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Adenosine</mesh_term>
	<mesh_term>Nitroprusside</mesh_term>
	<criteria>Age 1860 yr. All potential volunteer routine blood test screen hepatic , renal , hematological abnormality . Body mass index &lt; 27 Kg/m2 . Female volunteer childbearing potential undergo HCG pregnancy test screening study day . Pregnancy females Subjects unable give voluntary inform consent Subjects anticoagulant drug anemic Subjects recent medical illness Subjects history coronary heart disease Subjects know kidney liver disease Subjects history asthma Recent ( past three day ) use phosphodiesterase type 5 ( PDE5 ) inhibitor ( sildenafil , tadalafil vardenafil ) History intolerance adenosine nitroprusside History methemoglobinemia Use theophylline product Subjects hematological abnormality</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Adenosine</keyword>
	<keyword>Cytokines</keyword>
	<keyword>Inflammation</keyword>
	<keyword>VEGF</keyword>
</DOC>